Cosmetics and personal care manufacturers are heading into 2026 under sustained, compounding pressure rather than facing a single disruptive event. Regulatory scrutiny continues to intensify; ingredient expectations evolve, sustainability claims are challenged more aggressively, and product portfolios grow increasingly complex. At the same time, brands are expected to innovate faster, communicate more transparently, and adapt to shifting consumer sentiment without compromising safety or compliance.
For many organizations, the difficulty is not a lack of regulatory awareness or strategic intent. The difficulty lies in execution. Reformulations, packaging changes, supplier updates, and claims adjustments are happening more frequently and across more products than ever before. Each change introduces downstream consequences that must be managed carefully and consistently.
The trends below outline the most important operational pressures cosmetics and personal care manufacturers will face in 2026, and why disciplined product data governance increasingly determines resilience.
TL;DR
EU Cosmetics Regulation (EC No 1223/2009) is amended continuously through delegated acts. MoCRA mandates adverse event reporting within 15 business days (FDA).
Safety Gate 2024 data shows prohibited substances — including banned fragrance ingredient BMHCA — still appearing in marketed products.
The European Commission's 2021 study found 53% of green claims are vague, misleading, or unfounded, and 40% have no supporting evidence.
Commission Regulation (EU) 2023/1545 sets fragrance allergen disclosure thresholds: 0.001% for leave-on products, 0.01% for rinse-off products.
ECHA tested 4,686 products across 13 EU countries: 6% violated EU chemical regulations, with PFAS among common findings.
Cosmetics Europe reports EU cosmetics and personal care retail sales at €104 billion in 2024.
Cosmetics compliance tightens through frequent incremental updates rather than one headline change. That accumulation creates operational strain because manufacturers must identify impacted products quickly, then execute reformulation, relabeling, and market status changes without losing control of the portfolio.
The EU Cosmetics Regulation (EC No 1223/2009) operates through a steady stream of Commission delegated acts and technical amendments that restrict or reclassify ingredients, adjust concentration limits, and impose new labeling requirements. Change management for EU-registered products must therefore be continuous rather than episodic.
In the United States, the Modernization of Cosmetics Regulation Act of 2022 (MoCRA) established new federal requirements for cosmetic manufacturers, including mandatory serious adverse event reporting within fifteen business days, as confirmed by FDA MoCRA guidance. That requirement adds a structured traceability expectation: manufacturers must link product records, ingredient data, and market status to respond within the regulatory window.
Manufacturers that treat compliance as a portfolio capability — rather than a product-by-product reaction — are better positioned to absorb ongoing regulatory change without operational disruption. That requires ingredient data, product records, and change history to be connected and searchable across the full range.
Evidence
EU Cosmetics Regulation: EC No 1223/2009 and delegated acts (EUR-Lex)
MoCRA adverse event reporting: 15 business days — FDA MoCRA Guidance, 2024
Key Takeaway
EU Cosmetics Regulation (EC No 1223/2009) is amended continuously through delegated acts, not single headline changes. MoCRA requires cosmetics manufacturers to report serious adverse events to the FDA within 15 business days. Both frameworks demand that ingredient data, product records, and change history be connected and current — not reconstructed at the point of incident.
→ See how Trace One helps cosmetics manufacturers stay ahead of EU regulatory change
Regulators are demonstrating that cosmetic safety non-compliance is not theoretical. The risk is increasingly visible through market surveillance, rapid alert activity, and enforcement that pulls products off shelves and into public reporting systems.
The European Commission's Safety Gate Rapid Alert System 2024 report highlights cosmetics as a recurring category in product safety notifications. BMHCA — a synthetic fragrance ingredient prohibited under Annex II of EU Cosmetics Regulation — was among the most frequently flagged non-compliant substances in notified cosmetics products, illustrating how prohibited ingredients still surface in marketed products despite regulatory controls.
This enforcement reality makes supplier controls and formulation specification discipline essential. When approved formulations, restricted substance checks, and supplier declarations are not connected to the exact SKU and market version being sold, specification failures remain invisible until a product is already in the market.
The practical implication is that safety data must be structured, versioned, and tied to market authorization status at the product level — not held in disconnected files that must be manually assembled when a rapid alert or regulatory inquiry arrives.
Evidence
Safety Gate 2024: European Commission Safety Gate Rapid Alert System — 2024 Summary Report
BMHCA prohibition: Annex II, EU Cosmetics Regulation (EC No 1223/2009)
Key Takeaway
The European Commission's Safety Gate system flags cosmetics for prohibited substance violations on a recurring basis, with BMHCA — a banned synthetic fragrance — among the most frequently notified non-compliant ingredients in 2024. Enforcement is active and public. Manufacturers that cannot trace approved formulations to specific SKU and market versions cannot defend against rapid alert inquiries or market withdrawal notices.
→ Explore how Trace One connects formulation specs, supplier declarations, and SKU-level safety data
Sustainability claims remain commercially important, but scrutiny is rising and tolerance is shrinking. The operational difficulty is that claims often sit in marketing workflows while supporting evidence lives in formulation records, supplier documentation, and ingredient databases — making it hard to defend claims when regulators or retailers challenge them.
The European Commission's 2021 study on the substantiation of green claims found that 53 percent of green claims made by businesses provide vague, misleading, or unfounded information, while 40 percent of claims have no supporting evidence at all. Those figures describe both the prevalence of the problem and the enforcement direction under the EU Green Claims Directive, which is progressing through the legislative process.
Across a portfolio of several hundred cosmetics SKUs, a 53 percent unsubstantiated claims rate is not a marginal compliance issue — it is a material reputational and legal exposure. Each reformulation, supplier change, or packaging update can invalidate a previously accurate claim without triggering an automatic review unless claims are formally linked to the underlying product data.
In 2026, claims must be supported by traceable, consistent data rather than implied narratives. When formulations change, claims must be reassessed. When suppliers alter processes or sourcing, assumptions must be revisited. Informal review processes and undocumented decisions create exposure that is difficult to defend once challenged.
Evidence
EU green claims study: European Commission, 2021 — Study on Substantiation of Green Claims (DG JUST)
EU Green Claims Directive: COM/2023/166 — proposal published March 2023
Key Takeaway
The European Commission's 2021 study found that 53% of green claims are vague, misleading, or unfounded, and 40% have no supporting evidence. The EU Green Claims Directive will formalize substantiation requirements. For a manufacturer with hundreds of SKUs, unsubstantiated claims represent a scalable enforcement risk — especially when formulation or supplier changes invalidate claims that were previously accurate.
→ Learn how Trace One helps teams substantiate and maintain sustainability claims at portfolio scale
Ingredient disclosure is no longer only a label requirement. Retailers, marketplaces, and consumers increasingly expect structured ingredient and allergen information that stays consistent across packaging, ecommerce listings, and customer service channels — and that can be updated rapidly when formulations change.
Commission Regulation (EU) 2023/1545 expands fragrance allergen disclosure requirements under the EU Cosmetics Regulation, setting concentration thresholds that trigger mandatory labeling: 0.001 percent for leave-on products and 0.01 percent for rinse-off products. These thresholds require manufacturers to track allergen concentrations accurately at formula level and propagate updates correctly into labels and product content wherever they appear.
For manufacturers operating across multiple markets and channels, the operational challenge is consistency at scale. When ingredient data is fragmented across spreadsheets, PDFs, and disconnected systems, discrepancies emerge between the label, the product information file, the retailer portal, and the ecommerce listing. Each discrepancy represents a potential compliance gap or consumer trust failure.
Manufacturers need ingredient data that is structured, versioned, and reusable across outputs. Centralizing and governing ingredient data at formula level reduces the cost of updates, ensures consistency, and allows allergen thresholds to be checked systematically rather than manually.
Evidence
Fragrance allergen thresholds: Commission Regulation (EU) 2023/1545 (EUR-Lex)
Restricted substances list: Annex III, EU Cosmetics Regulation (EC No 1223/2009)
Key Takeaway
Commission Regulation (EU) 2023/1545 sets fragrance allergen disclosure thresholds at 0.001% for leave-on products and 0.01% for rinse-off products. Manufacturers must track allergen concentrations at formula level and ensure those thresholds are reflected consistently across labels, product information files, retailer portals, and ecommerce listings — not checked once at launch.
Packaging is becoming one of the most visible sustainability priorities in beauty, but it is also a growing operational constraint. Packaging redesign decisions interact simultaneously with material availability, supplier capability, cost targets, and regulatory requirements — creating interdependencies that are difficult to manage without centralized specification control.
The EU Packaging and Packaging Waste Regulation (PPWR), published as Regulation (EU) 2025/40 in the Official Journal in January 2025, sets mandatory recyclability and recycled content requirements for packaging placed on the EU market. For cosmetics manufacturers, packaging decisions in 2026 are no longer purely commercial choices — they carry compliance consequences that vary by format, material, and market.
Grand View Research estimates the global refillable packaging market at USD 45.59 billion in 2024 and projects growth to USD 62.60 billion by 2030. For cosmetics brands, that trajectory reflects genuine commercial movement: refill formats are scaling from pilot programs into mainstream distribution. A manufacturer choosing refillable or mono-material formats at portfolio scale is managing dependencies across suppliers, logistics, and regulatory labeling simultaneously.
Managing packaging change at portfolio scale requires packaging data to be treated with the same rigor as formulations. Components must be versioned, linked to suppliers, and assessed consistently across products and markets. Without that structural discipline, brands face inconsistency, mislabeling, and compounding cost as packaging transitions accelerate.
Evidence
PPWR: Regulation (EU) 2025/40 — Official Journal, January 202
Refillable packaging market forecast: Grand View Research, 2024
Key Takeaway
PPWR (Regulation (EU) 2025/40) establishes mandatory recyclability and recycled content requirements for EU packaging. The global refillable packaging market is projected to grow from USD 45.59 billion in 2024 to USD 62.60 billion by 2030 (Grand View Research), signaling that packaging format transitions are scaling commercially — creating specification, supplier, and regulatory dependencies that cannot be managed product by product.
→ What you need to know about PPWR
Reformulation is becoming routine due to ingredient reassessment, restricted substance enforcement, and rising market expectations around safety and sustainability. The operational risk is not reformulation itself — it is the downstream cascade each reformulation triggers: safety documentation updates, claims reassessment, label changes, and sometimes market eligibility reviews.
The European Chemicals Agency (ECHA) conducted testing across 4,686 products from 345 companies across 13 EU countries and found that 6 percent violated EU chemical regulations, with PFAS among the most common non-compliant findings, as reported by the Financial Times. Across a portfolio of 500 cosmetics SKUs, a 6 percent non-compliance rate represents approximately 30 products with active regulatory exposure. Each requires a reformulation decision, a safety reassessment, and coordinated label and claims updates.
The compounding difficulty is concurrent change. When multiple reformulations are in progress simultaneously, each affecting shared ingredients, packaging components, or supplier relationships, the dependencies become invisible without structured change control. Teams lose track of which products are compliant, which are in transition, and which require further action.
Reformulations must automatically trigger downstream reviews, preserve historical versions, and make transition status visible across the portfolio. That discipline is the difference between reformulation as a controlled, auditable process and reformulation as a recurring source of compliance gaps.
Evidence
ECHA product testing — 4,686 products, 6% violation rate: Financial Times, 2024 (citing ECHA)
PFAS restriction under REACH: ECHA universal PFAS restriction proposal, February 2023
Key Takeaway
ECHA testing of 4,686 cosmetics and personal care products across 13 EU countries found 6% violated EU chemical regulations (Financial Times, 2024). Across a portfolio of 500 SKUs, that represents approximately 30 products with active compliance exposure. Each reformulation triggers downstream work across safety documentation, claims, labels, and market eligibility — changes that multiply in risk when managed manually across concurrent programs.
→ Discover how Trace One makes reformulation dependencies visible and change control auditable
Many cosmetics portfolios expand through line extensions, limited editions, and channel-specific variants. Each addition increases the maintenance burden, slows approvals, and creates risk when teams cannot see which products share formulas, packaging components, or market-specific regulatory constraints.
Cosmetics Europe reports that European cosmetics and personal care retail sales reached €104 billion in 2024. That scale reflects a market where portfolio expansion and competitive differentiation remain intense priorities. For manufacturers operating across that market, each additional SKU is also an additional compliance obligation — fragrance allergen thresholds to verify, safety assessments to maintain, claims to substantiate.
The governance gap emerges not from deliberate neglect but from structural invisibility. When portfolio data is held in disconnected systems, teams cannot see that two product lines share a supplier, a restricted ingredient, or a packaging component until something changes — and then the impact is discovered too late to manage proactively.
Portfolio governance in 2026 means making visibility a default, not a project. Manufacturers need to see which products share formulations, ingredients, or packaging components, and how changes ripple across multiple SKUs — before those changes are made, not after.
Evidence
EU cosmetics market scale: Cosmetics Europe — Forecasts, 2025-2032
Compliance obligations by product type: EU Cosmetics Regulation EC No 1223/2009 (EUR-Lex)
Key Takeaway
European cosmetics and personal care retail sales reached €104 billion in 2024 (Cosmetics Europe). At that market scale, portfolio governance is not a process preference — it is a commercial and compliance necessity. Manufacturers that cannot see shared formulations, shared ingredients, or shared packaging components across their SKU range cannot manage regulatory change, supplier transitions, or reformulation cascades proactively.
Beauty cycles remain fast, and launch velocity remains commercially important. The pressure is real: trend cycles are shorter, retailer ranging windows are fixed, and speed to shelf is a competitive differentiator. The difficulty is that speed increases error probability when approvals and documentation are managed manually, because the same change must be reflected across multiple records, markets, and channels simultaneously.
FDA MoCRA guidance confirms that serious adverse event reporting must happen within fifteen business days, and that reports must include a copy of the product label. A manufacturer that cannot produce the current label version for a specific market SKU within that window faces regulatory consequences that compound the original incident. The same structured product data that enables regulatory response also enables faster, more reliable launches.
The competitive advantage in 2026 lies not in moving faster through manual processes but in building speed into governed workflows. When approvals, documentation, and cross-functional handoffs are structured and systematic, teams can move quickly without creating the gaps that lead to recalls, rework, or regulatory exposure.
The manufacturers that compete most effectively are those that have reduced the friction in governed processes — not those that have bypassed governance to hit a launch date.
Evidence
MoCRA adverse event reporting requirements: FDA MoCRA Guidance, 2024
MoCRA facility registration and product listing: Guidance for Industry (FDA)
Key Takeaway
FDA MoCRA requires serious adverse event reports within 15 business days, including a copy of the current product label. A manufacturer without consistent label versioning across SKUs and markets cannot meet that requirement reliably. The same structured product data that supports regulatory response also supports faster, more reliable launches — governed speed and compliance readiness are the same operational capability.
For cosmetics and personal care manufacturers, 2026 will be shaped by cumulative pressure rather than singular change. Regulatory expectations tighten incrementally — through EU Cosmetics Regulation amendments, MoCRA enforcement, PPWR implementation, and EU Green Claims Directive progression. Sustainability scrutiny intensifies. Supplier accountability increases. Portfolios continue to grow in complexity.
All of these pressures converge at product level. The ability to manage formulations, ingredients, packaging, suppliers, and claims as connected, governed data determines whether change feels controlled or chaotic. Manufacturers that invest in product data discipline are better positioned to absorb ongoing change and protect brand trust.
Those that rely on fragmented tools and manual coordination will find that even small adjustments carry disproportionate risk. In 2026, resilience comes less from predicting the next trend and more from being prepared to manage continuous evolution.
Trace One is a premier SaaS provider of Product Lifecycle Management (PLM) and compliance solutions, specializing in the food & beverage, cosmetics, personal care, and chemical industries. With over 30 years of expertise, Trace One empowers more than 9,000 brand owners worldwide to innovate, collaborate, and bring products to market faster while ensuring the highest standards of quality, compliance, and sustainability. Visit traceone.com.
Trusted by Global Industry Leaders
Trace One PLM is trusted by some of the world’s most demanding food & beverage, cosmetics, and specialty chemical brands, including Barilla, Ocean Spray, Suntory Global Spirits, Shiseido, Brown-Forman, Bacardi, Mars Wrigley, Ferrero, McCormick, Lindt & Sprüngli, Ghirardelli, Cargill, Innocent, Ahold Delhaize, Tesco, Carrefour, Monoprix, Campari, Moët Hennessy, UNFI, AAK, Naos, Glico, Europastry, Continental Mills, Sensient, Francap, and Franprix.
Connect with Federico on LinkedIn